Trademark: 79284173
Status Date
Tuesday, August 10, 2021
Registration Number
6443402
Registration Date
Tuesday, August 10, 2021
Filing Date
Monday, March 30, 2020
Published for Opposition
Tuesday, May 25, 2021
5 Pharmaceutical products for human use, namely, products for the treatment of diseases and disorders of the immune system, inflammatory diseases and disorders, oncological diseases and disorders and viral infections
The wording "BELCANZI" has no meaning in a foreign language.
May 24, 2023
International Registration Renewed
Feb 20, 2022
Final Decision Transaction Processed By Ib
Jan 13, 2022
Generic Madrid Transaction Sent To Ib
Jan 13, 2022
Generic Madrid Transaction Created
Nov 10, 2021
Final Disposition Notice Created, To Be Sent To Ib
Aug 10, 2021
Registered-Principal Register
May 30, 2021
Notification Processed By Ib
May 25, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Published For Opposition
May 5, 2021
Notification Of Possible Opposition Sent To Ib
May 5, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 5, 2021
Notification Of Notice Of Publication E-Mailed
Apr 15, 2021
Approved For Pub - Principal Register
Apr 15, 2021
Teas/Email Correspondence Entered
Apr 15, 2021
Correspondence Received In Law Office
Apr 15, 2021
Assigned To Lie
Jan 11, 2021
Teas Response To Office Action Received
Aug 25, 2020
Refusal Processed By Ib
Jul 28, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Jul 28, 2020
Refusal Processed By Mpu
Jun 20, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Jun 19, 2020
Non-Final Action Written
Jun 18, 2020
Assigned To Examiner
May 1, 2020
Application Filing Receipt Mailed
Apr 27, 2020
New Application Office Supplied Data Entered
Apr 23, 2020
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
